Canada Pension Plan Investment Board
MNTA

Canada Pension Plan Investment Board’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,500
Closed -$150K – 1454
2020
Q2 		$150K Buy
+4,500
New +$143K ﹤0.01% 1231

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Canada Pension Plan Investment Board's MNTA Position: Q3 2020 in Review

Canada Pension Plan Investment Board sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 4,500 shares — an estimated $150K sold.

Canada Pension Plan Investment Board first reported a position in MNTA in Q2 2020 and held it in 1 quarter. The position peaked at $150K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Canada Pension Plan Investment Board reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 4,500 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $150K.
  • Canada Pension Plan Investment Board first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Canada Pension Plan Investment Board's Momenta Pharmaceuticals, Inc. position peaked at $150K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Canada Pension Plan Investment Board's 13F filing for Q3 2020, filed 12 Nov 2020.